Skip to main content
FinSpry Logo
FinSpry
BGLC logo
BGLC
(NASDAQ)
BioNexus Gene Lab Corp.
$2.21-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BioNexus Gene Lab (BGLC) Stock Price & Financial Analysis

BioNexus Gene Lab Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.19 - $2.27
52-Week High$15.60
52-Week Low$1.92
Open$2.27
Volume1.59K
Average Volume (3M)1.59K
Market Cap3.97M
Shares Outstanding1.80M
Price to Sales (P/S)0.43
Price to Book (P/B)0.60
EV/EBITDA-1.43
Revenue (TTM)9.47M
Net Income (TTM)-2.30M
Free Cash Flow (TTM)-2.91M
EPS (TTM)$-1.28
Profit Margin-24.27%
Operating Margin-30.91%
Return on Equity (ROE)-33.70%
Debt to Equity0.03
50-Day MA$2.46
200-Day MA$4.28
52-Week Change-12.69%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About BioNexus Gene Lab

What is the current stock price for BGLC?

As of the latest trading session, BGLC stock trades at $2.21. The 52-week range is $1.92–$15.60, with a day range of $2.19–$2.27.

What is the P/E ratio for BGLC?

The P/E ratio (Price-to-Earnings) for BGLC is shown in the Key Statistics section. This valuation metric helps compare BioNexus Gene Lab Corp. to industry peers.

Does BGLC pay dividends?

BioNexus Gene Lab does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BGLC?

Analyst ratings and recommendations for BGLC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of BGLC?

BioNexus Gene Lab's market capitalization is $4.0M, classifying it as a micro-cap company. BioNexus Gene Lab operates in the Materials sector within the Specialty Chemicals industry.